By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first ...

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Novo Nordisk's Wegovy pill was prescribed 18,410 times in the U.S. in the first full week after its launch in an encouraging ...

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an "encouraging" ...

Jetset Select unveils the top global luxury hotspots for 2026 based on industry data and rising trends. Affluent ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

Make your running for weight loss journey one that goes beyond the numbers.

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

Researchers looked at birth weight, an important predictor of long-term health, in 11 million babies born in the United ...